BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 29891108)

  • 21. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Prognostic and Clinicopathological Roles of Sirtuin-3 in Various Cancers.
    Yu FY; Xu Q; Wu DD; Lau AT; Xu YM
    PLoS One; 2016; 11(8):e0159801. PubMed ID: 27483432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of platelet-derived growth factors in physiology and medicine.
    Andrae J; Gallini R; Betsholtz C
    Genes Dev; 2008 May; 22(10):1276-312. PubMed ID: 18483217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDGF receptors in tumor biology: prognostic and predictive potential.
    Paulsson J; Ehnman M; Östman A
    Future Oncol; 2014; 10(9):1695-708. PubMed ID: 25145436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factors and receptors in Canine Lymphoma.
    Aricò A; Guadagnin E; Ferraresso S; Gelain ME; Iussich S; Rütgen BC; Mazzariol S; Marconato L; Aresu L
    J Comp Pathol; 2014 Nov; 151(4):322-8. PubMed ID: 25172054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
    Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
    Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis.
    Figarella-Branger D; Vagner-Capodano AM; Bouillot P; Graziani N; Gambarelli D; Devictor B; Zattara-Cannoni H; Bianco N; Grisoli F; Pellissier JF
    Neuropathol Appl Neurobiol; 1994 Oct; 20(5):439-47. PubMed ID: 7531297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer.
    Donnem T; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
    Ann Oncol; 2010 Feb; 21(2):223-231. PubMed ID: 19628565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
    Yang C; Zou K; Zheng L; Xiong B
    BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis.
    Wang Y; He L; Cheng Y
    Clin Transl Oncol; 2018 Feb; 20(2):212-220. PubMed ID: 28681313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review.
    Zou X; Tang XY; Qu ZY; Sun ZW; Ji CF; Li YJ; Guo SD
    Int J Biol Macromol; 2022 Mar; 202():539-557. PubMed ID: 35074329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis.
    Cao Y
    Cell Cycle; 2005 Feb; 4(2):228-30. PubMed ID: 15655347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-derived growth factors and their receptors: structural and functional perspectives.
    Chen PH; Chen X; He X
    Biochim Biophys Acta; 2013 Oct; 1834(10):2176-86. PubMed ID: 23137658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
    Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
    Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
    Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
    Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparanase mRNA and Protein Expression Correlates with Clinicopathologic Features of Gastric Cancer Patients: a Meta- analysis.
    Li HL; Gu J; Wu JJ; Ma CL; Yang YL; Wang HP; Wang J; Wang Y; Chen C; Wu HY
    Asian Pac J Cancer Prev; 2015; 16(18):8653-8. PubMed ID: 26745132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 expression and patient survival in gastric cancer: a systematic review of the literature with meta-analysis.
    Cheng H; Wang X; Li T; Chen L
    Med Oncol; 2015 Jan; 32(1):389. PubMed ID: 25428392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis.
    Zhang Z; Tang H; Lin J; Hu Y; Luo G; Luo Z; Cheng C; Wang P
    Oncotarget; 2017 Mar; 8(10):17202-17215. PubMed ID: 28199988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis.
    Ling Z; Li R
    Int J Biol Markers; 2014 Jun; 29(2):e99-e111. PubMed ID: 24242292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.